Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?

Chronic pulmonary aspergillosis (CPA) is estimated to affect 3 million people worldwide making it an under recognised, but significant health problem across the globe, conferring significant morbidity and mortality. With variable disease forms, high levels of associated respiratory co-morbidity, lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, Gemma E., Novak-Frazer, Lilyann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753080/
https://www.ncbi.nlm.nih.gov/pubmed/29376935
http://dx.doi.org/10.3390/jof2020018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753080/
https://www.ncbi.nlm.nih.gov/pubmed/29376935
http://dx.doi.org/10.3390/jof2020018

Ejemplares similares